CTIS2023-506655-19-00招募中1 期
A Phase II, Multicenter Induction Study with an Active Treatment Extension to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis - GA44839
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Diagnosis of UC for at least 3 months, Moderately to severely active UC, assessed by Modified Mayo Score (mMS), Inadequate response, loss of response to, or intolerance to conventional or advanced therapies for UC
排除标准
- •Diagnosis of Crohn’s disease or indeterminate colitis, Suspicion of ischemic, radiation, microscopic, or infectious colitis, Prior colectomy, Prior treatment with systemic Janus kinase (JAK) inhibitors
研究者
相似试验
Enrolling By Invitation
2 期
A phase II, multicenter, single-arm study of Induction therapy with LDK378 followed by surgery in patients with ALK fusion-positive Stage II/III non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000017906ational Cancer Center HospitalEast19
进行中（未招募）
1 期
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal FailureShort Bowel Syndrome-associated Intestinal Failure (SBS-IF)MedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-000176-11-DEHanmi Pharmaceutical Co., Ltd.18
进行中（未招募）
1 期
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal FailureShort Bowel Syndrome-associated Intestinal Failure (SBS-IF)MedDRA version: 20.1Level: PTClassification code: 10049416Term: Short-bowel syndrome Class: 100000004856CTIS2024-515160-32-00Hanmi Pharm. Co. Ltd.16
进行中（未招募）
1 期
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal FailureEUCTR2021-000176-11-DKHanmi Pharmaceutical Co., Ltd.18
进行中（未招募）
1 期
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal FailureShort Bowel Syndrome-associated Intestinal Failure (SBS-IF)MedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-000176-11-BEHanmi Pharmaceutical Co., Ltd.18